Life science News and Research

RSS

Common diabetes drug could be repurposed as a treatment for autoimmune disorders

Swansea University researchers have found that a drug commonly used to treat type 2 diabetes can potentially be used in the treatment of autoimmune disorders.

25 May 2023

Opentrons Flex™ Lab Robot Launches to Accelerate Bioautomation Across Thousands of Life Science Experiments

Opentrons, a leader in lab automation, announces the launch of its Opentrons Flex robot, a new generation of affordable and easy-to-program liquid-handling lab robots designed to level the playing field for labs of all sizes and bring advanced lab automation to more researchers than ever before.

From Opentrons 22 May 2023

Democratizing RNA sequencing: A breakthrough in cost and efficiency

CSEM has supported the Lausanne-based start-up Alithea Genomics in developing a technology capable of processing hundreds of ribonucleic acid (RNA) samples in a single tube, which translates to a significant reduction in reagents and manual effort in the overall workflow.

From CSEM 17 May 2023

Nemours Children's Health selected to conduct first gene therapy clinical trial for Morquio A syndrome

As part of the Foundation for the National Institutes of Health Accelerating Medicines Partnership Bespoke Gene Therapy Consortium, Nemours Children's Health has been chosen to conduct a first-of-its-kind gene therapy clinical trial for Morquio A syndrome.

16 May 2023

MGI's DNBSEQ-T20×2 wins BEYOND Healthcare Innovation Award

MGI Tech Co. Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, today is proud to announce that its DNBSEQ-T20×2 ("T20") gene sequencing platform has been awarded the BEYOND Healthcare Innovation Award.

From MGI 15 May 2023

Medicines for All Institute at VCU receives $18.7 million grant to improve access to medicines

The Medicines for All Institute at Virginia Commonwealth University will work on 14 new global health projects and expand its capabilities to improve access to medicines around the world thanks to an $18.7 million grant from the Bill & Melinda Gates Foundation.

11 May 2023

ELRIG UK appoints Nick Clare to board as Vendor Strategy Work Group Lead

The European Laboratory Research & Innovation Group (ELRIG) UK today announced the appointment of Nick Clare to the ELRIG board. He will chair and lead the Vendor Strategy Work Group to help ensure the vendors’ perspectives and interests are represented within the ELRIG board.

From ELRIG (UK) Ltd. 11 May 2023

Laboratory instrument manufacturer from berlin honored with vorsprung award at the chancellor's office

On May 9, 2023, the VORSPRUNG Business Award, an accolade of the East German Business Forum OWF, was presented in Berlin at the Federal Chancellery.

From KNAUER Wissenschaftliche Geräte GmbH 11 May 2023

MGI Launches Overseas Production Line of DNBSEQ-G400* Sequencer in Latvia

Riga, Latvia, 8 May 2023 – LATVIA MGI TECH, SIA, ("MGI Latvia") a subsidiary of MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, today announced the official opening of its large-scale production line in Latvia. As MGI's largest regional hub for the European market, the facility based in Riga will see assembly and production of DNBSEQ-G400* gene sequencing instruments and HotMPS** reagents.

From MGI 10 May 2023

MGI Empowers the Completion of Nearly 60,000 Samples for The Million Microbiome of Humans Project

...

From MGI 10 May 2023

Study shows the power of gamma enhancement as potential approach for countering depression

Led by researchers from NYU Grossman School of Medicine and Hungary's University of Szeged, a new study in mice and rats found that restoring certain signals in a brain region that processes smells countered depression.

9 May 2023

Intratumoral bacteria linked with natural purple photosynthetic bacteria show strong anticancer efficacy

Cancer remains one of the leading causes of death worldwide. Researchers are constantly looking for new therapies with improved anticancer activity, fewer side effects, and lower costs.

8 May 2023

Manipulating microglia behavior with light

An international research team, comprising scientists from DZNE, University Hospital Bonn, the Netherlands, and the US has been awarded a US$ 1.3 million grant by the "Human Frontier Science Program" to investigate brain immune cells and manipulate them via light irradiation.

5 May 2023

The Evolution of Molecular Biology

In this interview, Istvan Szatmari, the Head of The Genomic Core Facility at the Department of Biochemistry and Molecular Biology, talks to NewsMed about the evolution of Molecular Biology.

From MGI 4 May 2023

The African Personalized Medicine Agenda

In this interview, Rizwana Mia, the Senior Program Manager at South African Medical Research Council, talks to News Medical about the African personalized medicine agenda.

From MGI 4 May 2023

How the COVID pandemic has improved genomics

In this interview, Davide Cacchiarelli, Molecular Biology and Genomics Professor at the University of Naples talks to NewsMed about how the COVID pandemic has highlighted the vital role of genomic surveillance and improved genomics.

From MGI 4 May 2023

The Human Protein Atlas and Precision Medicine

In this interview, Mathias Uhlen, the Director of the Human Protein Atlas, talks to NewsMed about the Human Protein Atlas and Precision Medicine.

From MGI 4 May 2023

MGI and South Australian Genomics Centre Introduce DNBSEQ-T7 to Supercharge Genomics Research in Australia

Brisbane, Australia 27th April 2023 - MGI and South Australian Genomics Centre (SAGC) are proud to announce their joint efforts to advance genomics research in Australia by introducing the country's first commercial ultra-high throughput sequencer DNBSEQ-T7*, through MGI's local distributor Decode Science.

From MGI 27 Apr 2023

MGI Announces New Customer Experience Center in South Korea with BMS

Cheonan, South Korea, 26 April 2023 – MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, today celebrated the opening of its Customer Experience Center (CEC) in South Korea. In partnership with one of the country’s leading companies in life science technology, BMS (Bio-Medical science Co., Ltd.), the new CEC based in Cheonan aims to provide local customers and partners with the first-hand access to MGI's cutting-edge products.

From MGI 27 Apr 2023

MGI Secured First Corporate Order of Ultra-high Throughput Sequencer DNBSEQ-T20×2*

Shanghai, China, April 25th, 2023 — MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technology to lead life science, announced its partnership with Shanghai-based JMDNA Biomedical Technology Co., Ltd. (“JMDNA”) for DNBSEQ-T20×2 (“T20”), a sequencer that broke records for its ultra-high throughput and cost-efficiency. This was the first corporate order of the T20 sequencer that MGI has secured worldwide.

From MGI 27 Apr 2023

Life science News and Research

Common diabetes drug could be repurposed as a treatment for autoimmune disorders

Opentrons Flex™ Lab Robot Launches to Accelerate Bioautomation Across Thousands of Life Science Experiments

Democratizing RNA sequencing: A breakthrough in cost and efficiency

Nemours Children's Health selected to conduct first gene therapy clinical trial for Morquio A syndrome

MGI's DNBSEQ-T20×2 wins BEYOND Healthcare Innovation Award

Medicines for All Institute at VCU receives $18.7 million grant to improve access to medicines

ELRIG UK appoints Nick Clare to board as Vendor Strategy Work Group Lead

Laboratory instrument manufacturer from berlin honored with vorsprung award at the chancellor's office

MGI Launches Overseas Production Line of DNBSEQ-G400* Sequencer in Latvia

MGI Empowers the Completion of Nearly 60,000 Samples for The Million Microbiome of Humans Project

Study shows the power of gamma enhancement as potential approach for countering depression

Intratumoral bacteria linked with natural purple photosynthetic bacteria show strong anticancer efficacy

Manipulating microglia behavior with light

The Evolution of Molecular Biology

The African Personalized Medicine Agenda

How the COVID pandemic has improved genomics

The Human Protein Atlas and Precision Medicine

MGI and South Australian Genomics Centre Introduce DNBSEQ-T7 to Supercharge Genomics Research in Australia

MGI Announces New Customer Experience Center in South Korea with BMS

MGI Secured First Corporate Order of Ultra-high Throughput Sequencer DNBSEQ-T20×2*

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News